| Jennifer Prussman, PHARMD | |
|
1440 N Campus Dr, Brookings, SD 57007-2480 | |
| (605) 688-5410 | |
| Not Available |
| Full Name | Jennifer Prussman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1440 N Campus Dr, Brookings, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952180747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6031 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Prussman, PHARMD 1205 Keystone Cir, Brookings, SD 57006-4662 Ph: (507) 412-9989 | Jennifer Prussman, PHARMD 1440 N Campus Dr, Brookings, SD 57007-2480 Ph: (605) 688-5410 |
News Archive
Patients with first-episode psychosis who also present with substance abuse have a higher rate of hospitalisation after 12 months than their peers who do not, an Italian study reports.
On rare occasion, the light-sensing photoreceptor cells in the eye misfire and signal to the brain as if they have captured photons, when in reality they haven't. For years this phenomenon remained a mystery. Reporting in the June 10 issue of Science, neuroscientists at the Johns Hopkins University School of Medicine have discovered that a light-capturing pigment molecule in photoreceptors can be triggered by heat, as well, giving rise to these false alarms.
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced the launch of its Medicaid Managed Care Resource Center.
A study in the April 1 issue of the journal SLEEP demonstrates that low socioeconomic status independently predicts the poor acceptance of continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea, and patients with higher incomes are more likely to begin treatment.
Teva Pharmaceutical Industries Ltd. announced today that lipegfilgrastim achieved its primary endpoint of reducing the duration of severe neutropenia in a Phase III study designed to evaluate the efficacy and safety of lipegfilgrastim (XM22) compared to pegfilgrastim (Amgen's Neulasta™).
› Verified 8 days ago
Melanie Lunn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 812 Candlewood Ln, Brookings, SD 57006 Phone: 605-695-5380 | |
Lori Couser, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 22nd Ave S, Brookings, SD 57006 Phone: 605-692-7311 | |
Dr. Lindsay Anne Haleta, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 6th St, Brookings, SD 57006 Phone: 605-692-1858 Fax: 605-697-5313 | |
Dana Culver, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 22nd Ave S, Brookings, SD 57006 Phone: 605-692-7311 | |
Maureen A. Logue, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 22nd Ave S, Brookings, SD 57006 Phone: 605-692-7311 | |
Bridget Stewart, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 6th St, Brookings, SD 57006 Phone: 605-692-1858 | |
Angela Lafleur, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 6th St, Brookings, SD 57006 Phone: 605-692-1858 Fax: 605-697-5313 |